Classic clinical criteria and associated findings for the diagnosis of Kawasaki disease.
Epidemiologic Case Definition (Classic Clinical Criteria)
A) Fever persisting at least 5 days
B) Presence of at least 4 principal features:
(Patients with fever at least 5 days and <4 principal criteria can be diagnosed with Kawasaki disease when coronary artery abnormalities are detected by 2-dimensional echocardiography or angiography)
1) Changes in extremities
• Acute: erythema of palms, soles; edema of hands, feet
• Subacute: periungual peeling of fingers, toes in wk 2 and 3
2) Polymorphous exanthem
3) Bilateral bulbar conjunctival injection without exudate
4) Erythema and cracking of lips, strawberry tongue, and/or erythema of oral and pharyngeal mucosa
5) Cervical lymphadenopathy (>1.5 cm diameter), usually unilateral
C) Exclusion of other diseases with similar findings
*These features do not have to occur concurrently.
Other Clinical and Laboratory Findings
A) Cardiovascular System
• Myocarditis, pericarditis, valvular regurgitation, shock
• Coronary artery abnormalities
• Aneurysms of medium-sized noncoronary arteries
• Peripheral gangrene
• Aortic root enlargement
B) Respiratory System
• Peribronchial and interstitial infiltrates on chest radiograph
• Pulmonary nodules
C) Musculoskeletal System
• Arthritis, arthralgias (pleocytosis of synovial fluid)
E) Central Nervous System
• Extreme irritability
• Aseptic meningitis (pleocytosis of cerebrospinal fluid)
• Facial nerve palsy
• Sensorineural hearing loss
F) Genitourinary System
• Urethritis/meatitis, hydrocele
G) Other Findings
• Desquamating rash in groin
• Retropharyngeal phlegmon
• Anterior uveitis by slit-lamp examination
• Erythema, induration at bacille Calmette-Guérin inoculation site
Laboratory Findings in Acute Kawasaki Disease
• Leukocytosis with neutrophilia and immature forms
• Elevated erythrocyte sedimentation rate
• Elevated C-reactive protein
• Anemia
• Abnormal plasma lipids
• Hypoalbuminemia
• Hyponatremia
• Thrombocytosis after wk 1
• Sterile pyuria
• Elevated serum transaminases
• Elevated serum γ-glutamyl transpeptidase
• Pleocytosis of cerebrospinal fluid
• Leukocytosis in synovial fluid
Source: From McCrindle BW, Rowley A, Newburger JW et al: Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association, Circulation 135(17):e927–e999, 2017.
Doctaverse is suggestion-only clinical decision support for qualified clinicians,
not a medical device or a substitute for examination, local protocols, or primary guidelines.
It is not for patients or parents.
By continuing you confirm you are a qualified healthcare professional and agree to our
Terms of Use and Privacy Policy.
We use analytics cookies to understand usage and improve the site. See our Privacy Policy.